GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Net Policyholder Benefits/Claims

SillaJen (XKRX:215600) Net Policyholder Benefits/Claims


View and export this data going back to 2016. Start your Free Trial

What is SillaJen Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


SillaJen Business Description

Industry
Traded in Other Exchanges
N/A
Address
6F, 252, Geumjeong-ro, Geumjeong-gu, Busan, KOR, 46274
SillaJen Inc is a Korean based biotechnology company focused on engineering and developing cancer treatment cells. The company along with its subsidiary SillaJen Biotherapeutics, Inc offers Pexa-Vec, an oncolytic virus with antibodies, and improved survival in a randomized trial to cure cancer; and JX929, an engineered vaccinia virus strain that acts on cancer cells by viral attack and subsequent cancer cell oncolysis. SillaJen operates its business activities in Korea and United States.